1. Ibrahim A, Fahal AH. Recovery of radiologically functionless obstructed kidneys. Br J Urol. 1984; 56: 113-115.PMID: 6498428.
2. Fahal AH, Ibrahim A. Post – prostatectomy auto-irrigation with furosemide in the tropics. Pharmatherapeutic. 1986; 4(9): 590-594.PMID: 3094037.
3. Fahal AH. Acute Scrotum – Review article. Post Gradate Doctor. 1987; 10(5): 272-278.
4. Fahal AH, Yagi KI. Skin Endometriosis in Sudan. Trop Geogr Med. 1987; 39: 383-384.PMID: 3451419.
5. Fahal AH, Hassan MA. Fournier’s Gangrene in Khartoum. Br J Urol. 1988; 61: 451-454.PMID: 3293689.
6. Ahmed ME, Fahal AH. Preoperative fasting state in patients undergoing elective surgery. Emirates Med J. 1988; 6: 135-137.
7. EL Nour SAM, Fahal AH. Vertebral Solitary Osteochondroma. Saudi Med J. 1988; 9(6): 622-626.
8. Fahal AH, McDollan A M, Marston A. Femorofemoral bypass in unilateral iliac artery occlusion. Br J Surg. 1989; 76: 22-25. PMID:2917255.
9. Ahmed ME, Fahal AH. Acute gluteal abscesses. Injectable chloroquine as a cause. J Trop Med Hyg. 1989; 92: 317-319.
10.Babekir ARE, Fahal AH, HedietAlla A. Oesophageal carcinoma in Sudan. Trop Doct. 1989; 19: 33-34.. PMID: 2922814.
11. Fahal AH, Gad EL Rab MO, EL Abdin SZ. The immune status of Sudanese patients with gastrointestinal tract cancer. Sudan Med J. 1990; 28(1-4): 23-29.
12.EL Zaki K, Ahmed MELM, EL Hassan AM, Yousif MA, Fahal AH. Acute gluteal abscess following intramuscular chloroquine injection: A clinical and experimental study. J Trop Med Hyg. 1991; 98: 206-209.PMID: 2051527.
13.Fahal AH, Hassan MA. Mycetoma. Br J Surg. 1992; 79(11): 1138-1141.PMID: 1467883.
14. Fahal AH, Sahil RB, Suliman SH, Hassan MA. Acute scrotum conditions in Khartoum. Sudan Med J. 1992; (1): 29-39.
15.Ezedeen K, Fahal AH, Ahmed ME. Management of hand infection in Khartoum. East Afr Med J. 1992; 69(11): 616- 618.PMID: 1298617.
16.Fahal AH, Suliman SH, Yagi KI, Gadir AFA, Mukhtar BI, Malik MOA. Salivary gland tumours in Sudan. East Afr Med J. 1993; 70(4): 213-216.
17. Fahal AH, Anwer AG, Suliman SH, Hassan MA. Appendicular mass in Khartoum. Sudan Med J. 1993; 39(1): 86-97.
18.Fahal AH, Suliman SH, Sharfi AR, EL Mahdi MEA. Acute idiopathic scrotal oedema in association with diabetic septic foot. Diabetes Res Clin Pract. 1993; 21(2-3):197-200.PMID: 8269822.
19. Fahal AH, Suliman SH, Gadir AFA, EL Hag IA, EL Amin FI, Gumaa SA, Mahgoub ES. Abdominal wall mycetoma: an unusual presentation. Trans R Soc Trop Med Hyg. 1994; 88(1):78-80.PMID: 8154012.
20. Fahal AH, Suliman SH. Clinical presentation of mycetoma. Sudan Med J. 1994; 32: 46-66.
21.Fahal AH, El Hassan AM, Abdelalla AO, Sheik HE, Cystic mycetoma: an unusual clinical presentation of Madurella mycetomatis. Trans R Soc Trop Med Hyg. 1998; 92:6-67.
22. Fahal AH. Pneumatosis cystoid intestinalis. Review article. Sudan Med J. 1994; 32(1): 1-8.
23.Fahal AH, EL Toum EA, EL Hassan AM, Gumaa SA, Mahgoub ES. A preliminary study on the ultrastructure of Actinomadura pelletieri and its host tissue reaction. J Med Vet Mycol. 1994; 32: 343-348.PMID: 7844700.
24. EL Hassan AM, Fahal AH, EL Hag IA, Khalil EAG. The pathology of mycetoma: Light microscopic and ultrastructural features. Sudan Med J. 1994; 32: 23-45.
25. Fahal AH, Hassan MA, Sanhouri M. Surgical treatment of mycetoma. Sudan Med J. 1994; 32: 98-104.
26.Fahal AH, Barka OZ, EL Lider AM. Pneumatosis cystoid intestinalis. (A case report). East Afr Med J. 1994; 71(6): 401-402.PMID: 7835266.
27.Fahal AH, EL Toum EA, EL Hassan AM, Gumaa SA, Mahgoub ES. Host tissue reaction to Madurella mycetomatis: New classification. J Med Vet Mycol. 1995; 33: 15-17.
28.EL Hag IA, Fahal AH, Khalil EAG. Fine needle aspiration cytology of mycetoma. Acta Cytologica. 1996; 40(3): 461-46.
29.Fahal AH, EL Hag IA, EL Hassan AM, Hashim FA. Leishmanialcholecystitisand colitis in a patient with visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1995; 89: 284.PMID: 7660434.
30.Fahal AH, EL Razig SA, Suliman SH, Ibrahim SZ, Tigani AE. Gastrointestinal tract cancer in association with hepatitis and HIV infection. East Afr Med J.1995; 72(7): 424-426.PMID: 7660434.
31.Fahal AH, Omer SM, El Razig SA, Ali ABE, Mahdi EMA, Mahgoub ES. Thyroid function in mycetoma patients. East Afr Med J. 1995; 72(7): 454-456.PMID: 7498029.
32.Fahal AH, Nasr A. Scrotal sepsis – Review article. Surgery. 1995; 13(8): 2-3.
33.Fahal AH, Azziz KAA, Suliman SH, Galib HV, Mahgoub ES. Dual infection with mycetoma and tuberculosis. East Afr Med J. 1995; 72(11): 749-750.PMID: 8904072.
34.Musa MT, Fahal AH, EL Arabi YE. Aspiration sclerotherapy for Hydroceles in the Tropics. Br J Urol. 1995; 76:488-490.PMID: 7551889.
35.Fahal AH, Gadir AFA, Nasr IO. Penile ossification. East Afr Med J. 1996; 73(4): 276-277.PMID: 8706616.
36.Mohamed ARO, Fahal AH, Venge V. Immunoglobulin and inflammatory markers profile in mycetoma. East Afr Med J. 1996; 73(4): 212 (Letter).PMID: 8698027.
37.FadlAlla AI, Fahal AH, Ahmed ME, Hassan MA. Pattern of postoperative pyrexia in Khartoum. East Afr Med J. 1996; 73 (1): 78-80.PMID: 8625871.
38.Sourkati EOM, Fahal AH, Suliman SH, EL Razig SA. Intestinal obstruction in Khartoum. East Afr Med J. 1996; 73(5): 31-34.PMID: 8756035.
39.Fahal AH, Yagi HI, EL Hassan AM. Mycetoma induced palatal deficiency and pharyngeal plexus dysfunction. Trans R Soc Trop Med Hyg. 1996; 90: 676-677.PMID: 9015514
40.Fahal AH, Sheikh HE, EL Hassan AM. Pathological fracture in mycetoma. Trans R Soc Trop Med Hyg. 1996; 90: 675-676.PMID: 9015513.
41.Fahal AH, Sharfi AR, Sheikh HE, EL Hassan AM. Mycetoma: Uncommon complication. Trans R Soc Trop Med Hyg. 1996; 89: 550-552.
42.Fahal AH, Sadig ME, Suliman SH, EL Razig SA, Mahgoub ES. Lack of association between ABO blood groups and Rh factor and the tendency to develop mycetoma. East Afr Med J. 1996; 11: 769. (Letter).PMID: 8997873
43.EL Mahdi EMA, Kadaro AY, Fahal AH, EL Awad MS, EL Bagir MN, Mohammed SA, Idris AET, Muktar E. Type 1 diabetes mellitus in the Sudan. Epidemiological features and complications. Sudan Med J. 1996; 34(1): 12-18.
44.Fahal, AH, EL Hag IA, Gadir AFA, EL Lider AR, Baraka OZ, EL Hassan AM. The blood supply and vasculature in mycetoma. J Med Vet Mycol. 1997; 35: 101-106.PMID: 9147269
45.Fahal AH, Sheikh HE, EL Lider MA, Homeida MA, EL Arabi YE, Mahgoub ES. Ultrasonic imaging in mycetoma. Br J Surg. 1997; 78: 765-766.PMID: 9278658
46.Fahal AH, Barido NO, Gadir AFA, EL Arabi YE. Calculi within an anal fistula tract. Br J Surg. 1994; 84:1001.PMID: 9240147.
47.Ahmed AOA, Fahal AH, Abugroun EAM, Zijlstra E, Belkum A van, Verbrugh HA. Unexpected high prevelance of secondary bacterial infection in mycetoma. J Clin Microbiol. 1998; 36(3): 850-851.
48.Ahmed AOA, van Belkum A, Fahal AH, EL nor AEA, Abougroum EAM, Vanden Bergh MFQ, Zijlsra EE, Verbrugh HA. Nasal cariage of staphylococcus aureus and epidemiology of surgical –site infection in a Sudanese university hospital. J Clin Microbiol. 1998; 36(12): 14-18.PMID: 9817883.[Download free Article].
49.Fahal AH, Sharfy ARA. Vulval mycetoma: a rare cause of bladder outlet obstruction. Trans R Soc Trop Med Hyg. 1998; 92: 652-653.PMID: 10326112.
50.Ahmed AO, Mukhtar MM, Kools-Sijmons M, Fahal AH, de Hoog S, van den Ende BG, Zijstara, ED, Verburgh H, Abugroun ESA, EL Hassan AM, van Beklkum A. Development of a species-specific PCR RFLP procedure for the identification of Madurella mycetomatis. J Clin Microbiol. 1999; 37(10):3175-8.PMID: 10488173. [Download Free Article]
51.Fahal AH, Zijlstar EE. Keloid en hypertofishelittekens WCS Nieuws 1998; 2(6): 21-25.
52.Fahal AH. The management of mycetoma. Post-Grad -Caribbean. 2000;16(4):229-232.
53.Mahdi SEI, Ahmed AO, Boelens H, Ott A, Abugroun, ES, van Belkum A, Verbrugh H, Fahal AH. An epidemiological study on the occurrence of StaphylococusAureus in superficial abscesses of patients presenting for surgery in a teaching hospital in Khartoum, Sudan. FEMS Immunol Med Microbiol. 2000; 29:155-162.PMID: 11024355. [Download Free Article].
54.EL Hassan AM, Fahal AH, Ahmed AO, Ismail A, Veress B. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Med Hyg. 2001: 95(1); 89-92.PMID: 11280076
55.Ahmed AOA, Adelmann D, Fahal AH, Verbrugh HA, Van Belkum A, De Hoog S. Environmental occurrence of Madurella mycetomatis, major agent of human eumycetoma in Sudan. J Clin Microbiol. 2002 40(3): 1031-1036.PMID: 11880433. [Download Free Article]
56.Masri MA, Abdel Seed NM, Fahal AH, Romano M, Baralle F, El Hassam AM, Ibrahim ME. Minor role for BRCA2 (exon11) and p53 (exon 5-9) among Sudanese breast cancer patients. Breast Cancer Research and Treatment. 2002; 71(2):145-7.PMID: 11883440.
57.Ahmed AOA, van Vianen W, ten Kate M, van de Sande WWJ, Van Belkum A, Fahal AH, Verbrugh HA, Bakker- Woudenberg IAJM. A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol. 2003; 37: 29-36.PMID: 12770757. [Download Free Article].
58.Ahmed AOA, van de Sande W, Van Belkum A, Verbrugh HA, Fahal A H, van Belkum A. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol. 2003; 41(10):4537-41PMID: 14532179. [Download free article]
59. Abd Bagi ME, Fahal AH, Sheik HE, Abdul Wahab O, Taifoor MK, Osmanr EM. High incidence of pathological fracture in mycetoma. Trans R Soc Trop Med Hyg. 2003; 97(5):582-4. PMID: 15307432
60.Fahal AH. Mycetoma thorn on the flesh Review article. Trans R Soc Trop Med Hyg. 2004; 98(1):3-11. Review.
61. Ahmed AO, van de Sande WW, van Vianen W, van BelkumA, Fahal AH, Verbrugh HA, Bakker-WoudenbergIA.In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother. 2004; 48(7):2742-6.PMID: 15215141. [Download Free Article].
62.Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004; 4(9):566-74. Review.PMID: 15336224
63.EL Hassan AM, Fahal AH, Veress B. Cell phenotypes, immunoglobulins, and complement in lesion of eumycetoma caused by Madurella mycetomatis. Sud J Dermato 2006; 4 (1):2-5.
64.van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol. 2007; 179(5):3065-74.PMID: 17709521. [Download Free Article].
65.van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, Verbrugh H, van Belkum A. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect. 2007; 9: 1114-1123.PMID: 17644456.
66.van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Madurella mycetomatis compounds cross-reactive with galactomannan are detectable in culture supernatant but not in serum. J Med Microbiol. 2007; 56: 869-70.PMID: 17510278. [Download Free Article].
67.Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. CurrOpin Infect Dis. 2007; 20(2):146-51. PMID: 17496572.
68.van de Sande WW, Fahal AH, Riley TV, Verbrugh H, van Belkum A. In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J AntimicrobChemother. 2007; 59(3):553-5PMID: 17324961. [Download Free Article].
69.Fahal AH. Medical Education in the Sudan. The strengths and weakness. Medical Teach. 2007; 29(9):910-14.PMID: 18158664.
70.Hussein A, Ahmed AEM, Fahal AH, Mahmoud A, Sidig A. Awad K, Ahmed EM. Cervical cord compression secondary to mycetoma infection. Sud J Pub Health. 2007; 2(2): 112-115.
71.Quintana ET, Wierzbicka K, Mackiewicz P, Osman A, Fahal AH, Hamid ME, Zakrzewska-Czerwinska J, Maldonado LA, Goodfellow M. Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma. Antonie Van Leeuwenhoek. 2008; 93(3):305-13.PMID: 18157699.
72.DejanStojković, Marina Soković, Ana Džamić, MihailoRistić, Ahmed Fahal SilvanaPetrović, IvanaDjujić Sami Khalid. In vitro Susceptibility of Actinomadura madurae Clinical Isolates to Turpentine Oil of Pinuspinaster and α-Pinene. Arch. Biol. Sci., Belgrade. 2008; 60 (4): 697-701.
73.Abd El-Bagi MEB, Fahal AH. Mycetoma revisited. Incidence of various radiographic signs. Saudi Med J. 2009;30(4):529-33.PMID: 19370281.
74.Yousif BM, Fahal AH, Yahia MY. The Cell Block Technique: A New Diagnostic Tool for Mycetoma. Trans R Soc Trop Med Hyg. 2010; 104(1):6-9.
75.Fahal AH, Abu Sabaa. AH. Mycetoma in Children. Trans R Soc Trop Med Hyg. 2010; 104: 117–12.PMID: 19716573.
76.Fahal, AH. Management of mycetoma. Expert Rev Dermatol. 2010; 5(1), 87–93.
77.van de Sande WWJ, Fahal AH, Tavakol M, van Belkum A, Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol. 26.2.2010; 48(7):959-68., PMID: 20184498
78.van de Sande WW, Fahal AH, Bakker-Woudenberg IA, van Belkum A. Madurella Mycetomatis is not susceptible to the Echinocandin class of antifungal agents. Antimicrob Agents Chemother. 2010june, 54(6):2738-2740.PMID: 20350944
79.Darwish A, Nasr AO, Elhassan LA and Fahal AH Cyclosporine-A Therapy induced Multiple Bilateral Breast and Accessory Axillary Breast Fibroadenoma. J Med Case Reports. 2010; 11(4): 267.PMID: 20701786.
80.Fahal AH. Continuing Professional Development in Medical & Health Professions. International J Sud Research, 2010; 1(1): 29-34.
81.Fahal AH, Rahman I A, El-Hassan AM, EL Rahman ME, Zijlstra EE. The efficacy of itraconazole in the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011; 105(3):127-32.
82.Alex van Belkum, Ahmed H. Fahal, Wendy W.J va n de Sande. In Vitro Susceptibility of Madurella Mycetomatis to Posaconazole and Terbinafine. Antimicrob Agents Chemother. 2011; 55(4):1771-3.
83.Zubair Amin, Jack Boulet, David A. Cook, Rachel Ellaway, Ahmad Fahal, Roger Kneebone, Moira Maley, Doris Ostergaard, GomindaPonamperuma, Andy Wearn, AmitaiZiv. Technology-Enabled Technology-enabled assessment of health professions education: Consensus statement and recommendations from the Ottawa 2010 conference. Medical Teacher 2011; 33( 5): 364–369
84.Fahal AH, EL Sheik H, El Hassan AM. Venous Varicosity in Mycetoma. Sudan Med J. 2011; 47(1): 20-24.
85.Abdelrahman MYH, Mustafa MB, Fahal AH. Educational technology in surgery. Sudan Med J 2010; 46(3):152-159.
86.Fahal AH. Mycetoma. Review article, Khartoum Med J. 2011; 4(1): 514-523.
87.Omer TA, EL Hassan LAM, EL Hassan AM, Fahal AH A rare presentation of Xanthogranulomatous appendicitis and CaecalAngio-lipoma in one patient. Sudan Med J. 2011; 46(4):
88.de Klerk N, de Vogel C, Fahal AH, van belkum A, van de Sande W. fructose-bisphosphatealdolase and pyruvate kinase, two novel immunogens in madurella mycetomatis. Med Mycol. 2012; 50(2):143-51.
89.Paul A Hoskisson, Ralph Kirby, VartulSangal, Nicholas P Tucker, JolantaZakrzewska-Czerwinska, KatarzynaWierzbicka, Paul R Herron, Chun-Jong Chu, Dr. govindchandra, Ahmed Fahal, Michael Goodfellow. The draft genome sequence of the human pathogen Streptomyces somaliensis, a significant cause of actinomycetoma. J Bacteriol. 2012; 194(13):3544-5.
90.Zein HAM, Fahal AH, Mahgoub, ES, EL Hassan T, Abdel Rahman, ME, The Predictors of Cure, Amputation & Follow-up dropout among Mycetoma Patients as seen at The Mycetoma Research Centre, University of Khartoum. Trans R Soc Trop Med Hyg. 2012; 106(11):639-44.
91.Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW. Pleurostomophoraochracea, a novel agent of human eumycetoma with yellow grains.J Clin Microbiol. 2012; 50(9):2987-94
92.Mhmoud NA, Fahal AH, van de Sande WW. CD4+ T-lymphocytopenia in HIV-negative tuberculosis patients in Sudan. J Infect. 2012; 65(4):370-2.
93.de Hoog GS, van Diepeningen AD, Mahgoub el-S, van de Sande WW. New species of Madurella, causative agents of black-grain mycetoma. J Clin Microbiol. 2012; 50(3):988-94.
94.Fahal AH, Arbab MAR, EL Hassan AM. Aggressive Clinical Presentation of Mycetoma due to Actinomadura Pelletierii. Khartoum Med J. 2012; 5(1): 699-702.
95.Mohamed, EW, Suleiman HS, Fadella, AI, Fahal, AH. Aggressive Perineal and Pelvic Eumycetoma: An unusual and challenging problem to treat. Khartoum Med J. 2012; (5)2:771-774.
96.Wendy Kloezen, Jacques F. Meis, IlseCurfs-Breuker, Ahmed Fahal, Wendy W. J. van de Sande. In vitro antifungal activity of isavuconazole to Madurella mycetomatis. Antimicrob Agents Chemother. 2012; 56(11):6054-6.
97.Mohamed EW, Mohamed, ENA, Yousif, BM, Fahal, AH. Tongue Actinomycetoma due to Actinomadura madurae: A rare clinical presentation. J Oral Maxillofac Surg. 2012; 70(11):e622-4.
98.EL Shamy, ME, Fahal AH, Shakir MY, Homedia MMA. New MRI Grading System for the Diagnosis and Management of Mycetoma. Trans R Soc Trop Med Hyg. 2012; 106(12):738-42.
99.Fahal AH, van de Sandy, WW. The Epidemiology of mycetoma. Current Fungal Infection Reports. 2012; 6( 4): 320-326
100. Suleiman AM, Fahal AH, Oral Eumycetoma: A rare and unusual Presentation. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Available online 30 May 2012
101. Mhmoud NA, Fahal AH, van de SandeWW.The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation. Med Mycol. 2012 Dec 4. [Epub ahead of print]
102. Mohamed YH Abdelrahman, Mayson B Mustafa, Shahd A Osman, Hanadi Hassan, Ahmed Hassanain, Ahmed H. Fahal. Assessing information and communication technology in surgical training, Sudan as example. South Sudan Med J. 2012; 5(3): 66-68.
103. Fahal, AH, The Mycetoma Research Centre, University of Khartoum, Sudan: a success story that need support. IJSR. 2013 3(1): 1-13.
104. Elagab EAM, Mukhtar MM, Fahal AH, van de Sande WWJ. Peripheral Blood Mononuclear Cells of mycetoma patients react different to M. mycetomatis antigens than healthy endemic controls. PLOS neglected Dis – Accepted.
105. Ibrahim AI, EL Hassan AM, Fahal AH, EL Farag MM, Mahmmoud A. Identification of the Black Pigment & Heavy Metals in M. mycetomatis Grains using Histo-Biochemical Techniques. PLoS One,published 06 Mar 2013 | PLOS ONE10.1371/journal.pone.0057774.
106. Fahal AH, Shahan S. Orthopaedics Aspects of mycetoma. J Bone & Joints (Bri) – Accepted
107. Jaap J. van Hellemond, Alieke G. Vonk, Corné de Vogel, Rob Koelewijn, Norbert Vaessen, Ahmed Fahal, Alex van Belkum, Wendy W.J. van de Sande. Predisposition towards mycetoma during schistosomiasis – PLOS neglected Dis – Accepted
108. Al Dawi AF, Mustafa MI, Fahal AH, EL Hassan AM, Bakhiet SM, Mahgoub ES, Mergani A, Mukhtar MM. The possible association of HLA-DRB1 & HLA-DQB1 and the occurrence of Eumycetoma. Khartoum Med. J –Accepted
109. Suleiman HS, EL Hassan LAM, Fahal AH. Long Standing Gluteal Mass: An Uncommon Presentation of Tuberculosis. Khartoum Med J –Accepted.
110. Fahal AH, Elkhawad AO. “Treating Mycetoma: Guidelines for Best Practice in Developing Countries”- Expert Dermatology- in press
111. GS de Hoog, S. Abdalla Ahmed, MJ Najafzadeh, DA Sutton, M. SaradeghiKeisari, AH Fahal, U. Eberhart, B. Stielow, GJ Verkley, LianXin, WWJ van de Sande. Phylogenetic findings suggest possible new habitat and routes of infection of human eumycetoma. PLOS Neglected Diseases
112. Osman AH, Ezaldeen EA, Ali BM, Jacoub AO, Suleiman SH, Fahal AH. Poor Infusion Therapy Knowledge among Young Doctors in Two Tertiary Teaching Hospitals in Khartoum State. Khartoum Med J – In press
113. van de Sande, Wendy W. J.; Fahal, Ahmed H.; Goodfellow, Michael; Maghoub, El Sheikh;etal.Merits and Pitfalls of Currently Used Diagnostic Tools in Myeloma.PLOS Neglected Diseases
114. Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH (2014) Mycetoma Medical Therapy. PLOS Neglected Diseases
115. Ahmed SA, Kloezen W, Duncanson F, Zijlstra EE, de Hoog GS,Fahal AH. etal. (2014). Madurella mycetomatis Is Highly Susceptible to Ravuconazole.PLOS Neglected Diseases.
116. Ezaldeen EA, Fahal AH, Osman A (2013). Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience.PLOS Neglected Diseases
117. Fahal A, Mahgoub ES, EL Hassan AM, Abdel-Rahman ME, Alshambaty Y,Fahal AH, etal. (2014). A New Model for Management of Mycetoma in the Sudan.PLOS Neglected Diseases.
118.: Ahmed SA, van den Ende BHGG, Fahal AH, van de Sande WWJ, de Hoog GS (2014). Rapid Identification of Black Grain Eumycetoma Causative Agents Using Rolling Circle Amplification. PLOS Neglected Diseases
119. Verwer PEB, Notenboom CC, Eadie K,Fahal AH, Verbrugh HA, van de Sande WWJ (2015) . A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study. PLOS Neglected Diseases
120. Geneugelijk K, Kloezen W, Fahal AH, van de Sande WWJ (2014). Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma. PLOS Neglected Diseases.
121. Mhmoud NA, Fahal AH, Mahgoub ES, van de Sande WWJ (2014) . The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection.PLOS Neglected Diseases .
122. Elfadil H, Fahal AH, Kloezen W, Ahmed EM,van de Sande W (2015). The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent. PLOS Neglected Diseases .
123. Fahal AH, Mahgoub ES, EL Hassan AM,Jacoub AO, Hassan D (2015) . Head and Neck Mycetoma : The Mycetoma Research Centre Experience . PLOS Neglected Diseases
124. Ibrahim AI, El Hassan AM, Fahal AH, van de Sande WW (2013). A Histopathological Exploration of the Madurella mycetomatis Grain. PLOS Neglected Diseases.
125. van Hellemond JJ, Vonk AG, de Vogel C, Koelewijn R, Vaessen N,Fahal AH, et al (2013). Association of Eumycetoma and Schistosomiasis. PLOS Neglected Diseases.
126. Samy AM, van de Sande WWJ, Fahal AH, Peterson AT (2014). Mapping the Potential Risk of Mycetoma Infection in Sudan and South Sudan Using Ecological Niche Modeling. PLOS Neglected Diseases.
127. van de Sande WWJ, Maghoub ES, Fahal AH, Goodfellow M, Welsh O, etal. (2014) .The Mycetoma Knowledge Gap: Identification of Research Priorities .PLOS Neglected Diseases.
128. Zijlstra, Eduard E.; van de Sande, Wendy W. J.; Mahgoub, ElSheikh; Goodfellow, Michael; Fahal, Ahmed H(2016). Mycetoma: a unique neglected tropical disease. Lancet Infectious Diseases,Volume 16, Issue 1, January 2016, Pages 100–112
